rs150485422

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001875.5(CPS1):​c.2909A>G​(p.Asn970Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,611,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N970D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 2.90

Publications

3 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030182421).
BP6
Variant 2-210640009-A-G is Benign according to our data. Variant chr2-210640009-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 567695.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000368 (56/152294) while in subpopulation AFR AF = 0.0012 (50/41556). AF 95% confidence interval is 0.000937. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.2909A>Gp.Asn970Ser
missense
Exon 24 of 38NP_001866.2
CPS1
NM_001369256.1
c.2942A>Gp.Asn981Ser
missense
Exon 25 of 39NP_001356185.1
CPS1
NM_001122633.3
c.2909A>Gp.Asn970Ser
missense
Exon 25 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.2909A>Gp.Asn970Ser
missense
Exon 24 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.2927A>Gp.Asn976Ser
missense
Exon 25 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.1556A>Gp.Asn519Ser
missense
Exon 14 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.000348
AC:
53
AN:
152176
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000139
AC:
35
AN:
251146
AF XY:
0.0000958
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000167
AC:
243
AN:
1458926
Hom.:
0
Cov.:
28
AF XY:
0.000153
AC XY:
111
AN XY:
726034
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33398
American (AMR)
AF:
0.0000671
AC:
3
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86198
European-Finnish (FIN)
AF:
0.0000189
AC:
1
AN:
52990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.000163
AC:
181
AN:
1109880
Other (OTH)
AF:
0.000166
AC:
10
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000368
AC:
56
AN:
152294
Hom.:
0
Cov.:
32
AF XY:
0.000322
AC XY:
24
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41556
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000193
Hom.:
0
Bravo
AF:
0.000344
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Congenital hyperammonemia, type I (3)
-
1
-
CPS1-related disorder (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
Pulmonary hypertension, neonatal, susceptibility to;C4082171:Congenital hyperammonemia, type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
14
DANN
Benign
0.91
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.060
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.030
T
MetaSVM
Uncertain
-0.013
T
MutationAssessor
Benign
-0.72
N
PhyloP100
2.9
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.49
N
REVEL
Benign
0.26
Sift
Benign
0.69
T
Sift4G
Benign
0.58
T
Polyphen
0.0
B
Vest4
0.037
MVP
0.90
MPC
0.18
ClinPred
0.035
T
GERP RS
5.4
Varity_R
0.13
gMVP
0.33
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150485422; hg19: chr2-211504733; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.